Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolo Riggi

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Swiss Medical Weekly|December 4, 2018
Synovial sarcoma: when epigenetic changes dictate tumour developmentNicolo Riggi, Luisa Cironi, Ivan Stamenkovic
Annual Review of Pathology|October 26, 2017
Cancer Metastasis: A Reappraisal of Its Underlying Mechanisms and Their Relevance to TreatmentNicolo Riggi, Michel Aguet, Ivan Stamenkovic
Expert Review of Anticancer Therapy|August 13, 2009
Ewing's sarcoma origin: from duel to dualityNicolo Riggi, Mario-Luca Suva, Ivan Stamenkovic
Science (New York, N.Y.)|March 30, 2013
Epigenetic reprogramming in cancerMario L Suvà, Nicolo Riggi, Bradley E Bernstein
Cell Reports|October 26, 2018
Pan-Cancer Landscape of Aberrant DNA Methylation across Human TumorsSadegh Saghafinia, Marco Mina, Nicolo Riggi, et al.
Life Science Alliance|January 5, 2022
Necrotic debris and STING exert therapeutically relevant effects on tumor cholesterol homeostasisSampath Katakam, Santosh Anand, Patricia Martin, et al.
Dermatopathology (Basel, Switzerland)|November 9, 2019
β-Catenin Expression and Activation in Conjunctival MelanomaEmerentienne Larivé, Michael Nicolas, Gürkan Kaya, et al.
Genes & Development|December 13, 2016
IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancerNils Degrauwe, Mario-Luca Suvà, Michalina Janiszewska, et al.
Dermatopathology (Basel, Switzerland)|July 2, 2021
5-Hydroxymethylcytosine Loss in Conjunctival MelanomaAlexandre Stahl, Nicolo Riggi, Katya Nardou, et al.
Cancer Research|September 28, 2014
Targeting cancer stem-like cells as an approach to defeating cellular heterogeneity in Ewing sarcomaSandrine Cornaz-Buros, Nicolo Riggi, Claudio DeVito, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Swiss Medical Weekly|December 4, 2018
Synovial sarcoma: when epigenetic changes dictate tumour developmentNicolo Riggi, Luisa Cironi, Ivan Stamenkovic
Annual Review of Pathology|October 26, 2017
Cancer Metastasis: A Reappraisal of Its Underlying Mechanisms and Their Relevance to TreatmentNicolo Riggi, Michel Aguet, Ivan Stamenkovic
Expert Review of Anticancer Therapy|August 13, 2009
Ewing's sarcoma origin: from duel to dualityNicolo Riggi, Mario-Luca Suva, Ivan Stamenkovic
Science (New York, N.Y.)|March 30, 2013
Epigenetic reprogramming in cancerMario L Suvà, Nicolo Riggi, Bradley E Bernstein
Cell Reports|October 26, 2018
Pan-Cancer Landscape of Aberrant DNA Methylation across Human TumorsSadegh Saghafinia, Marco Mina, Nicolo Riggi, et al.
Life Science Alliance|January 5, 2022
Necrotic debris and STING exert therapeutically relevant effects on tumor cholesterol homeostasisSampath Katakam, Santosh Anand, Patricia Martin, et al.
Dermatopathology (Basel, Switzerland)|November 9, 2019
β-Catenin Expression and Activation in Conjunctival MelanomaEmerentienne Larivé, Michael Nicolas, Gürkan Kaya, et al.
Genes & Development|December 13, 2016
IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancerNils Degrauwe, Mario-Luca Suvà, Michalina Janiszewska, et al.
Dermatopathology (Basel, Switzerland)|July 2, 2021
5-Hydroxymethylcytosine Loss in Conjunctival MelanomaAlexandre Stahl, Nicolo Riggi, Katya Nardou, et al.
Cancer Research|September 28, 2014
Targeting cancer stem-like cells as an approach to defeating cellular heterogeneity in Ewing sarcomaSandrine Cornaz-Buros, Nicolo Riggi, Claudio DeVito, et al.
Pageof 4